Skip to main content

Articles

FDA Approvals, In the News
FDA Expands Use of Xalkori to Treat Rare Form of Advanced Non-Small Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves First Treatment for Rare Disease in Patients Who Receive Stem Cell Transplant from Blood or Bone Marrow
Read More
FDA Approvals, In the News
FDA Approves First Coagulation Factor-Albumin Fusion Protein to Treat Patients with Hemophilia B
Read More
Conquering COPD: Value-Based Perspectives for Providers and Payers
Read More
FDA Approvals, Payers' Guide
The Year 2015 Had Highest Number of Drug Approvals in the New Millennium, but with Controversy
Read More
FDA Approvals, Payers' Guide
FDA Approvals of Brand-Name Prescription Drugs in 2015
Read More
FDA Approvals, Payers' Guide
Welcome to the Seventh Annual Payers' Guide to New FDA Approvals
Read More
FDA Approvals, Payers' Guide
Aripiprazole Lauroxil (Aristada): Long-Acting Atypical Antipsychotic Injection Approved for the Treatment of Patients with Schizophrenia
Read More
FDA Approvals, Payers' Guide
Cosentyx (Secukinumab): First IL-17A Antagonist Receives FDA Approval for Moderate-to-Severe Plaque Psoriasis
Read More
FDA Approvals, Payers' Guide
Corlanor (Ivabradine), First HCN Channel Blocker, FDA Approved for the Treatment of Patients with Heart Failure
Read More
Page 114 of 244
Results 1131 - 1140 of 2434